128 related articles for article (PubMed ID: 14687614)
1. The angiogenic status of B-CLL B cells: role of the VEGF receptors.
Kay NE
Leuk Res; 2004 Mar; 28(3):221-2. PubMed ID: 14687614
[No Abstract] [Full Text] [Related]
2. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Bairey O; Boycov O; Kaganovsky E; Zimra Y; Shaklai M; Rabizadeh E
Leuk Res; 2004 Mar; 28(3):243-8. PubMed ID: 14687619
[TBL] [Abstract][Full Text] [Related]
3. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis under Delta-Notch couple control].
Suchting S; Freitas C; Eichmann A
Med Sci (Paris); 2007 Apr; 23(4):347-8. PubMed ID: 17433219
[No Abstract] [Full Text] [Related]
6. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
[TBL] [Abstract][Full Text] [Related]
7. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis.
Kerbel RS
N Engl J Med; 2008 May; 358(19):2039-49. PubMed ID: 18463380
[No Abstract] [Full Text] [Related]
9. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
10. [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?].
Grépin R; Pagès G
J Soc Biol; 2009; 203(2):181-92. PubMed ID: 19527632
[TBL] [Abstract][Full Text] [Related]
11. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
12. Localization and signaling patterns of vascular endothelial growth factors and receptors in human periapical lesions.
Virtej A; Løes SS; Berggreen E; Bletsa A
J Endod; 2013 May; 39(5):605-11. PubMed ID: 23611377
[TBL] [Abstract][Full Text] [Related]
13. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
Takahashi H; Shibuya M
Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
[TBL] [Abstract][Full Text] [Related]
14. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
[TBL] [Abstract][Full Text] [Related]
16. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?
de Bont ES; Neefjes VM; Rosati S; Vellenga E; Kamps WA
Leuk Lymphoma; 2002 Oct; 43(10):1901-9. PubMed ID: 12481883
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis regulated by VEGF and its receptors and its clinical application.
Shibuya M
Rinsho Ketsueki; 2009 May; 50(5):404-12. PubMed ID: 19483401
[No Abstract] [Full Text] [Related]
18. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
19. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
Shanafelt TD; Kay NE
Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
[TBL] [Abstract][Full Text] [Related]
20. The vascular endothelial growth factor family and its receptors.
Parikh AA; Ellis LM
Hematol Oncol Clin North Am; 2004 Oct; 18(5):951-71, vii. PubMed ID: 15474329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
